سعر اي في اف - ام 150 وحدة دولية فيال 2022

• Development of multiple follicles and pregnancy in ovulatory women as part of an assisted reproductive technology (ART) cycle.Population: Ovulatory women undergoing ARTDailyMed (U.S. National Library of Medicine)

• Most common (2% or more) in ART: abdominal cramps, abdominal enlargement, abdominal pain, headache, injection-site pain, reaction and inflammation, and OHSS.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Prior hypersensitivity to menotropins products or their excipients.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• High FSH levels indicating primary ovarian failure.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Pregnancy (may cause fetal harm).General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Should only be used by physicians experienced in infertility treatment, with appropriate monitoring facilities; use the lowest effective dose.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Risks include abnormal ovarian enlargement, ovarian hyperstimulation syndrome (OHSS), pulmonary and vascular (thromboembolic) complications, ovarian torsion, multi-fetal gestation, congenital malformations, ectopic pregnancy, spontaneous abortion and ovarian neoplasms.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Contraindicated in pregnancy; may cause fetal harm when given to a pregnant woman.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• It is not known whether menotropins are excreted in human milk; decide whether to discontinue nursing or the drug, considering the importance of the drug to the mother.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

English text not available for this section.